Alliance for Cancer Gene Therapy Anniversary Gala @ The Harvard Club

Alliance for Cancer Gene Therapy Anniversary Gala to Honor Dr. John Lahey with the first Edward Netter Award for Business and Industry
ACGT Gala Scheduled for April 19, 2017, and Also Features One of the First Patients Successfully Treated with Cancer Immunotherapy
Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, is celebrating its anniversary with a Gala on Wednesday, April 19, 2017, at 6:30pm at The Harvard Club of New York City.
Dr. John Lahey, president of Quinnipiac University, will be honored at the event with the first ever Edward Netter Award for Business and Industry for his contributions to ACGT and the community.
Gala speakers also include: ACGT research fellow Dr. Robert Vonderheide of the University of Pennsylvania, who will speak on the exciting breakthroughs using immunotherapy for the treatment of solid cancers; and Doug Olson, one of the first three patients treated in the groundbreaking cancer immunotherapy CAR-T clinical trial developed by ACGT research fellow and Scientific Advisory Council member, Dr. Carl June.
Tickets for the ACGT Gala are $750 and are available at http://www.acgtfoundation.org/events/ or by emailing Barbara Gallagher, ACGT national director of philanthropy at bgallagher@acgtfoundation.org.